2548 studies found for:    hormone therapy AND (woman OR women OR female)
Show Display Options
Download search resultsDownload the search results for:
hormone therapy AND (woman OR women OR female) (2548 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With Poor Prognosis, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving 3 Years of Adjuvant Hormone Therapy
Condition: ER-positive HER2-negative Breast Cancer
Interventions: Drug: Everolimus;   Drug: Placebo
2 Completed Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Recurrent Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: letrozole;   Biological: bevacizumab;   Other: laboratory biomarker analysis;   Other: questionnaire administration
3 Not yet recruiting Trastuzmab & Pertuzumab Alone or in Combination With Hormonal Therapy or Chemotherapy With Eribulin in Women Aged 60 and Over With HER2/Neu Overexpressed Locally Advanced or MBC
Condition: Metastatic Breast Cancer
Interventions: Drug: Trastuzumab plus Pertuzumab;   Drug: Hormonal Therapy with Anastrozole and Fulvestrant;   Drug: Chemotherapy with Eribulin
4 Active, not recruiting Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Tamoxifen;   Drug: Toremifene
5 Completed Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women
Condition: Postmenopause
Interventions: Drug: Estradiol and Progesterone;   Drug: Estradiol and Drospirenone
6 Active, not recruiting Compliance to a Hormone Therapy Regimen in Breast Cancer
Condition: Breast Cancer
Interventions: Behavioral: compliance monitoring;   Other: medical chart review;   Other: questionnaire administration
7 Recruiting Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Condition: Invasive Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrazole
8 Completed Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Condition: Breast Cancer
Interventions: Drug: chemotherapy;   Drug: endocrine therapy;   Genetic: DNA methylation analysis;   Genetic: protein analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
9 Completed Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
Conditions: Hypercholesterolemia;   Postmenopause
Interventions: Drug: L-arginine;   Drug: Estrogen
10 Active, not recruiting Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Conditions: Breast Cancer;   Cancer of the Breast;   Neoplasms, Breast
Intervention: Drug: Estrace followed by anastrazole
11 Active, not recruiting Memory Study of Youngest Women Enrolled in the Women's Health Initiative Hormone Therapy (HT) Arm
Condition: All Cause Dementia
Intervention: Drug: Prem-Pro
12 Completed Growth Hormone Treatment of Women With Turner Syndrome
Condition: Turner Syndrome
Interventions: Drug: Growth Hormone;   Drug: Placebo;   Other: Healthy controls
13 Terminated High-Dose Esterified Estrogens in Treating Postmenopausal Women With Metastatic Breast Cancer That Has Failed Previous Hormone Therapy
Condition: Breast Cancer
Intervention: Biological: esterified estrogens
14 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: anastrozole;   Drug: letrozole;   Drug: exemestane;   Radiation: radiation therapy;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
15 Active, not recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Letrozole;   Other: Placebo
16 Completed Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention: Drug: letrozole
17 Unknown  Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention:
18 Active, not recruiting Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Letrozole
19 Unknown  Paclitaxel, Cyclophosphamide, and Doxorubicin Followed by Autologous Dendritic Cells and Surgery With or Without Radiation Therapy and/or Hormone Therapy in Treating Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: therapeutic autologous dendritic cells;   Drug: aromatase inhibition therapy;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Genetic: gene expression analysis;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: adjuvant therapy;   Procedure: biopsy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
20 Completed Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: tamoxifen citrate;   Drug: toremifene

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years